Owens & Minor (NYSE:OMI) Releases Q4 2024 Earnings Guidance

Owens & Minor (NYSE:OMI) updated its fourth quarter 2024 earnings guidance on Monday. The company provided earnings per share guidance of 0.520-0.550 for the period, compared to the consensus earnings per share estimate of 0.530. The company issued revenue guidance of $2.7 billion-$2.7 billion, compared to the consensus revenue estimate of $2.7 billion. Owens & Minor also updated its FY 2024 guidance to 1.500-1.530 EPS.

Wall Street Analysts Forecast Growth

OMI has been the subject of several recent analyst reports. Robert W. Baird decreased their price objective on shares of Owens & Minor from $19.00 to $14.00 and set a “neutral” rating for the company in a report on Tuesday, November 5th. Barclays dropped their price target on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 5th. UBS Group reduced their price objective on Owens & Minor from $28.00 to $25.00 and set a “buy” rating for the company in a research report on Tuesday, November 5th. Finally, Citigroup decreased their target price on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a research report on Tuesday, November 5th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Owens & Minor currently has an average rating of “Hold” and a consensus price target of $18.50.

Owens & Minor Trading Down 28.2 %

Shares of NYSE:OMI traded down $4.01 during mid-day trading on Monday, hitting $10.23. The stock had a trading volume of 1,504,415 shares, compared to its average volume of 546,443. The company’s 50 day moving average is $13.86 and its 200-day moving average is $14.32. Owens & Minor has a 12-month low of $10.54 and a 12-month high of $28.35. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09. The company has a market cap of $788.53 million, a PE ratio of -15.73, a P/E/G ratio of 0.40 and a beta of 0.48.

Owens & Minor (NYSE:OMI) last posted its quarterly earnings results on Monday, November 4th. The company reported $0.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. The business had revenue of $2.72 billion during the quarter, compared to analyst estimates of $2.68 billion. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The firm’s revenue was up 5.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.44 earnings per share. On average, sell-side analysts predict that Owens & Minor will post 1.49 EPS for the current year.

Insider Buying and Selling at Owens & Minor

In related news, CFO Jonathan A. Leon sold 5,282 shares of the stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $11.82, for a total transaction of $62,433.24. Following the completion of the sale, the chief financial officer now owns 130,822 shares in the company, valued at $1,546,316.04. This trade represents a 3.88 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 2.62% of the company’s stock.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.